202-19: Complex Topics in Substance Use: Drug Adulterants, Treatment Transitions, & Pregnancy

4.6 (5 votes)

202-19: Complex Topics in Substance Use: Drug Adulterants, Treatment Transitions, & Pregnancy

Examine hot topics in substance use disorders to gain an understanding of current and emerging needs, including: adulterants in the illicit drug supply and related harm reduction strategies; transitions in medication treatment for opioid use; and treatment of opioid use disorder during pregnancy and postpartum period.


Presenter:
  Matt Tierney, ANP, PMHNP, FAAN

Disclosures:  The speaker has indicated a significant financial interest or other affiliation with Johnson & Johnson, and participates in the Nursing Advisory Council on Opioids. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


Session Length:  1 hour 27 minutes

Target Audience:  RN, APRN


Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  1. Utilize several strategies to address the numerous dangers associated with adulterants in illicit drug supplies.
  2. Translate evidence-based knowledge and best-practice recommendations to assist patients in OUD treatment transition from methadone to buprenorphine.

Keywords:  Substance Use, Opioids, Psychopharmacology


Continuing Nursing Education:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


Originally Presented

APNA 17th Annual Clinical Psychopharmacology Institute
Louisville, KY
Saturday, June 8, 2019
9:45am - 11:15am


The contact hours for this session expire:  June 30, 2021

Components visible upon registration.